# Halozyme Therapeutics, Inc. (HALO)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/HALO/charts)

## P/E windows

| Window | Value |
| --- | --- |
| P/E1 | 30.15 |
| P/E2 | 25.18 |
| P/E3 | 27.73 |
| P/E4 | 31.07 |
| P/E5 | 30.65 |
| P/E6 | 32.32 |
| P/E7 | 38.57 |
| P/E8 | 45.20 |
| P/E9 | 48.56 |
| P/E10 | 58.05 |
| P/E11 | 66.72 |
| P/E12 | 74.71 |
| P/E13 | 86.05 |
| P/E14 | 97.60 |
| P/E15 | 108.28 |

Widest P/E window this company has the history to fill: 15 years. Shorter windows are still computed; longer ones are left empty rather than padded.

## Other views

- [Metrics](https://sponda.capital/en/HALO.md)
- [Fundamentals](https://sponda.capital/en/HALO/fundamentals.md)
- [Compare](https://sponda.capital/en/HALO/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.